Nano-X Imaging (NASDAQ:NNOX) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Nano-X Imaging (NASDAQ:NNOXFree Report) from a strong sell rating to a hold rating in a research note issued to investors on Monday,Zacks.com reports.

NNOX has been the topic of several other reports. Cantor Fitzgerald raised Nano-X Imaging to a “strong-buy” rating in a research note on Wednesday, March 4th. D. Boral Capital reissued a “buy” rating and issued a $5.00 price target on shares of Nano-X Imaging in a research note on Monday, April 20th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, April 10th. Three investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $5.00.

View Our Latest Stock Analysis on Nano-X Imaging

Nano-X Imaging Stock Down 6.8%

Shares of NNOX opened at $1.51 on Monday. The stock has a market capitalization of $105.08 million, a P/E ratio of -0.95 and a beta of 1.21. Nano-X Imaging has a twelve month low of $1.50 and a twelve month high of $5.69. The firm has a fifty day simple moving average of $1.88 and a two-hundred day simple moving average of $2.43.

Nano-X Imaging (NASDAQ:NNOXGet Free Report) last released its quarterly earnings data on Monday, April 20th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.35). The firm had revenue of $3.72 million during the quarter, compared to analysts’ expectations of $3.99 million. Nano-X Imaging had a negative net margin of 790.87% and a negative return on equity of 64.65%. During the same quarter in the previous year, the firm posted ($0.21) EPS. Sell-side analysts expect that Nano-X Imaging will post -0.65 EPS for the current fiscal year.

Hedge Funds Weigh In On Nano-X Imaging

Institutional investors and hedge funds have recently made changes to their positions in the business. Interchange Capital Partners LLC bought a new stake in shares of Nano-X Imaging in the 4th quarter worth approximately $28,000. Aristides Capital LLC purchased a new stake in shares of Nano-X Imaging in the 4th quarter worth approximately $30,000. CIBC Bancorp USA Inc. bought a new position in Nano-X Imaging during the 3rd quarter valued at approximately $40,000. Independent Financial Group LLC bought a new position in Nano-X Imaging during the 1st quarter valued at approximately $26,000. Finally, Kestra Advisory Services LLC purchased a new position in Nano-X Imaging during the first quarter valued at $26,000. Institutional investors own 21.49% of the company’s stock.

Nano-X Imaging News Summary

Here are the key news stories impacting Nano-X Imaging this week:

  • Neutral Sentiment: A class action lawsuit has been filed against Nano-X Imaging and certain officers, alleging securities-law violations during the March 31, 2025 to April 17, 2026 period. Article Title
  • Neutral Sentiment: Several plaintiff firms, including Rosen, Howard G. Smith, Schall, the Gross Law Firm, Faruqi & Faruqi, and others, issued notices reminding investors of the case and the August 11 lead-plaintiff deadline. Article Title
  • Negative Sentiment: The repeated lawsuit headlines may increase investor concern about potential financial liabilities and governance issues, adding pressure to an already weak stock. Article Title

About Nano-X Imaging

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.

Further Reading

Analyst Recommendations for Nano-X Imaging (NASDAQ:NNOX)

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.